As
the Center for Medicare Advocacy has highlighted throughout the pandemic,
communities of color are disproportionately affected by COVID-19, in terms of
rate and severity of illness. At the end of 2020, the news of the COVID-19
vaccine’s efficacy in studies brought much needed optimism that the end of the
pandemic was possible. However, actual rates of vaccinations and equity of
vaccine distribution were uncertain. Some states developed distribution plans that specifically
considered these disproportionate impacts.
Now
that vaccinations have begun across the country, some initial research has been
published. The overall vaccination rate has remained low in the
United States; as of the beginning of February 2021, just over 8% of the
population has been partially vaccinated and only 2% have been fully
vaccinated. Though eligibility guidelines vary, in most areas vaccines have
primarily been reserved for health care workers and residents and staff of
facilities. Data on vaccination rates by race/ethnicity is limited. Though
analysis of vaccination access and equity is limited in scope, some early data
points are troubling.
This
week the Kaiser Family Foundation released analysis from early vaccination rates, which
reveals some warning signs about racial disparities in access and
administration of COVID-19 vaccines. Across the 23 states reporting vaccination
data by race and ethnicity, there was a consistent pattern of Black and
Hispanic people receiving smaller shares of vaccinations compared to their
shares of cases and deaths and compared to their shares of the total
population.
The
CDC
also released demographic data this week reflecting
vaccinations in the US from the first month (December 14-January 14), which
also raised concerns. The report found that of those receiving vaccinations,
where CDC had demographic data, about 60% were White, 11% were Hispanic/Latino,
6% were Asian, and 5% were Black, though it stressed limitations due to lack of
comprehensive data.
The
CDC report called on additional data collection efforts in order to identify
and address potential disparities. “…[F]indings underscore the need for more
complete reporting of race and ethnicity data at the provider and
jurisdictional levels to ensure rapid detection of and response to potential
disparities in COVID-19 vaccine administration. Jurisdictions should monitor
the demographic characteristics of vaccinated persons to identify emerging
disparities.”
A New York Times report
had similar findings.
“Although low-income communities of color have been hit hardest
by Covid-19, health officials in many cities say that people from wealthier,
largely white neighborhoods have been flooding vaccination appointment systems
and taking an outsized share of the limited supply.” One example of this
contrast provided was Philadelphia, where only 12% of those inoculated were
Black, even though the city’s population is 44% Black.
Due
to this early data, some areas are attempting to target vaccinations directly
to communities most in need. The article cited plans in various cities aimed at
increasing vaccinations for those in hardest hit areas. Baltimore will offer
the vaccine in housing complexes for the elderly, going door-to-door, and
Washington, DC began offering vaccine appointments for zip codes with highest
rates of infection and death, before opening up appointments for other portions
of the city, as well as increasing the number of workers helping people get
appointments.
The new approaches based on the available data underscore the need for more detailed, standardized, comprehensive data on vaccination rates by race and ethnicity. Without more detailed data, required of all states, it will be challenging to address and adjust vaccine distribution to ensure communities suffering disproportionately from COVID-19 have access to vaccines. Vaccine hesitancy, particularly among groups hardest hit by the virus, is another issue that must be considered in policies that target vaccines to communities most in need. Polling from fall 2020 showed that vaccine concerns were prevalent in communities of color. Though support for the vaccine has increased over the last few weeks, these concerns, as well as the historical context in which they arise, must be considered when striving to increase vaccination rates.
No comments:
Post a Comment